Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 280

1.

Potential Red-Flag Identification of Colorectal Adenomas with Wide-Field Fluorescence Molecular Endoscopy.

Hartmans E, Tjalma JJJ, Linssen MD, Allende PBG, Koller M, Jorritsma-Smit A, Nery MESO, Elias SG, Karrenbeld A, de Vries EGE, Kleibeuker JH, van Dam GM, Robinson DJ, Ntziachristos V, Nagengast WB.

Theranostics. 2018 Feb 5;8(6):1458-1467. doi: 10.7150/thno.22033. eCollection 2018.

2.

Near-infrared fluorescence molecular endoscopy detects dysplastic oesophageal lesions using topical and systemic tracer of vascular endothelial growth factor A.

Nagengast WB, Hartmans E, Garcia-Allende PB, Peters FTM, Linssen MD, Koch M, Koller M, Tjalma JJJ, Karrenbeld A, Jorritsma-Smit A, Kleibeuker JH, van Dam GM, Ntziachristos V.

Gut. 2017 Dec 15. pii: gutjnl-2017-314953. doi: 10.1136/gutjnl-2017-314953. [Epub ahead of print] No abstract available.

3.

Inflammatory potential of the diet and colorectal tumor risk in persons with Lynch syndrome.

Brouwer JG, Makama M, van Woudenbergh GJ, Vasen HF, Nagengast FM, Kleibeuker JH, Kampman E, van Duijnhoven FJ.

Am J Clin Nutr. 2017 Nov;106(5):1287-1294. doi: 10.3945/ajcn.117.152900. Epub 2017 Sep 20.

PMID:
28931533
4.

Incidence of small bowel neoplasia in Lynch syndrome assessed by video capsule endoscopy.

Haanstra JF, Al-Toma A, Dekker E, Vanhoutvin SALW, Nagengast FM, Mathus-Vliegen EM, van Leerdam ME, de Vos Tot Nederveen Cappel WH, Veenendaal RA, Cats A, Sanduleanu S, Vasen HFA, Kleibeuker JH, Koornstra JJ.

Endosc Int Open. 2017 Jul;5(7):E622-E626. doi: 10.1055/s-0043-111723. Epub 2017 Jul 6.

5.

Strain-tuned enhancement of ferromagnetic TC to 176 K in Sm-doped BiMnO3 thin films and determination of magnetic phase diagram.

Choi EM, Kleibeuker JE, MacManus-Driscoll JL.

Sci Rep. 2017 Mar 3;7:43799. doi: 10.1038/srep43799.

6.

Hereditary cancer registries improve the care of patients with a genetic predisposition to cancer: contributions from the Dutch Lynch syndrome registry.

Vasen HF, Velthuizen ME, Kleibeuker JH, Menko FH, Nagengast FM, Cats A, van der Meulen-de Jong AE, Breuning MH, Roukema AJ, van Leeuwen-Cornelisse I, de Vos Tot Nederveen Cappel WH, Wijnen JT.

Fam Cancer. 2016 Jul;15(3):429-35. doi: 10.1007/s10689-016-9897-1.

7.

VEGF pathway targeting agents, vessel normalization and tumor drug uptake: from bench to bedside.

Arjaans M, Schröder CP, Oosting SF, Dafni U, Kleibeuker JE, de Vries EG.

Oncotarget. 2016 Apr 19;7(16):21247-58. doi: 10.18632/oncotarget.6918. Review.

8.

Molecular Fluorescence Endoscopy Targeting Vascular Endothelial Growth Factor A for Improved Colorectal Polyp Detection.

Tjalma JJ, Garcia-Allende PB, Hartmans E, Terwisscha van Scheltinga AG, Boersma-van Ek W, Glatz J, Koch M, van Herwaarden YJ, Bisseling TM, Nagtegaal ID, Timmer-Bosscha H, Koornstra JJ, Karrenbeld A, Kleibeuker JH, van Dam GM, Ntziachristos V, Nagengast WB.

J Nucl Med. 2016 Mar;57(3):480-5. doi: 10.2967/jnumed.115.166975. Epub 2015 Dec 17.

9.

Randomized Comparison of Surveillance Intervals in Familial Colorectal Cancer.

Hennink SD, van der Meulen-de Jong AE, Wolterbeek R, Crobach AS, Becx MC, Crobach WF, van Haastert M, Ten Hove WR, Kleibeuker JH, Meijssen MA, Nagengast FM, Rijk MC, Salemans JM, Stronkhorst A, Tuynman HA, Vecht J, Verhulst ML, de Vos Tot Nederveen Cappel WH, Walinga H, Weinhardt OK, Westerveld D, Witte AM, Wolters HJ, Cats A, Veenendaal RA, Morreau H, Vasen HF.

J Clin Oncol. 2015 Dec 10;33(35):4188-93. doi: 10.1200/JCO.2015.62.2035. Epub 2015 Nov 2.

PMID:
26527788
10.

CD44, SHH and SOX2 as novel biomarkers in esophageal cancer patients treated with neoadjuvant chemoradiotherapy.

Honing J, Pavlov KV, Mul VE, Karrenbeld A, Meijer C, Faiz Z, Smit JK, Hospers GA, Burgerhof JG, Kruyt FA, Kleibeuker JH, Plukker JT.

Radiother Oncol. 2015 Oct;117(1):152-8. doi: 10.1016/j.radonc.2015.08.031. Epub 2015 Sep 10.

PMID:
26364884
11.

Ulcerative colitis patients with an inflammatory response upon mesalazine cannot be desensitized: a randomized study.

Buurman DJ, De Monchy JG, Schellekens RC, van der Waaij LA, Kleibeuker JH, Dijkstra G.

Scand J Gastroenterol. 2015 Apr;50(4):399-405. doi: 10.3109/00365521.2014.962608. Epub 2015 Jan 29.

PMID:
25633468
12.

Adherence to surveillance guidelines after removal of colorectal adenomas: a large, community-based study.

van Heijningen EM, Lansdorp-Vogelaar I, Steyerberg EW, Goede SL, Dekker E, Lesterhuis W, ter Borg F, Vecht J, Spoelstra P, Engels L, Bolwerk CJ, Timmer R, Kleibeuker JH, Koornstra JJ, de Koning HJ, Kuipers EJ, van Ballegooijen M.

Gut. 2015 Oct;64(10):1584-92. doi: 10.1136/gutjnl-2013-306453. Epub 2015 Jan 13.

13.

Electronic reconstruction at the isopolar LaTiO(3)/LaFeO(3) interface: an X-ray photoemission and density-functional theory study.

Kleibeuker JE, Zhong Z, Nishikawa H, Gabel J, Müller A, Pfaff F, Sing M, Held K, Claessen R, Koster G, Rijnders G.

Phys Rev Lett. 2014 Dec 5;113(23):237402. Epub 2014 Dec 2.

PMID:
25526156
14.

GATA6 expression in Barrett's oesophagus and oesophageal adenocarcinoma.

Pavlov K, Honing J, Meijer C, Boersma-van Ek W, Peters FT, van den Berg A, Karrenbeld A, Plukker JT, Kruyt FA, Kleibeuker JH.

Dig Liver Dis. 2015 Jan;47(1):73-80. doi: 10.1016/j.dld.2014.09.014. Epub 2014 Oct 16.

PMID:
25445407
15.

Prevalence of small-bowel neoplasia in Lynch syndrome assessed by video capsule endoscopy.

Haanstra JF, Al-Toma A, Dekker E, Vanhoutvin SA, Nagengast FM, Mathus-Vliegen EM, van Leerdam ME, de Vos tot Nederveen Cappel WH, Sanduleanu S, Veenendaal RA, Cats A, Vasen HF, Kleibeuker JH, Koornstra JJ.

Gut. 2015 Oct;64(10):1578-83. doi: 10.1136/gutjnl-2014-307348. Epub 2014 Sep 10.

PMID:
25209657
16.

Ferroelectric Sm-doped BiMnO3 thin films with ferromagnetic transition temperature enhanced to 140 K.

Choi EM, Kursumovic A, Lee OJ, Kleibeuker JE, Chen A, Zhang W, Wang H, MacManus-Driscoll JL.

ACS Appl Mater Interfaces. 2014 Sep 10;6(17):14836-43. doi: 10.1021/am501351c. Epub 2014 Aug 28.

17.

Embryological signaling pathways in Barrett's metaplasia development and malignant transformation; mechanisms and therapeutic opportunities.

Pavlov K, Meijer C, van den Berg A, Peters FT, Kruyt FA, Kleibeuker JH.

Crit Rev Oncol Hematol. 2014 Oct;92(1):25-37. doi: 10.1016/j.critrevonc.2014.05.002. Epub 2014 May 12. Review.

PMID:
24935219
18.

Dietary B vitamin and methionine intake and MTHFR C677T genotype on risk of colorectal tumors in Lynch syndrome: the GEOLynch cohort study.

Jung AY, van Duijnhoven FJ, Nagengast FM, Botma A, Heine-Bröring RC, Kleibeuker JH, Vasen HF, Harryvan JL, Winkels RM, Kampman E.

Cancer Causes Control. 2014 Sep;25(9):1119-29. doi: 10.1007/s10552-014-0412-4. Epub 2014 Jun 12.

PMID:
24916333
19.

Predictors of colorectal neoplasia after polypectomy: based on initial and consecutive findings.

van Enckevort CC, de Graaf AP, Hollema H, Sluiter WJ, Kleibeuker JH, Koornstra JJ.

Neth J Med. 2014 Apr;72(3):139-45.

20.

Regulation of TRAIL receptor expression by β-catenin in colorectal tumours.

Jalving M, Heijink DM, Koornstra JJ, Boersma-van Ek W, Zwart N, Wesseling J, Sluiter WJ, de Vries EG, Kleibeuker JH, de Jong S.

Carcinogenesis. 2014 May;35(5):1092-9. doi: 10.1093/carcin/bgt484. Epub 2013 Dec 30.

PMID:
24379239
21.

Quality colonoscopy and risk of interval cancer in Lynch syndrome.

Haanstra JF, Vasen HF, Sanduleanu S, van der Wouden EJ, Koornstra JJ, Kleibeuker JH, de Vos Tot Nederveen Cappel WH.

Int J Colorectal Dis. 2013 Dec;28(12):1643-9. doi: 10.1007/s00384-013-1745-2. Epub 2013 Jul 16.

PMID:
23857598
22.

Dietary Supplement Use and Colorectal Adenoma Risk in Individuals with Lynch Syndrome: The GEOLynch Cohort Study.

Heine-Bröring RC, Winkels RM, Botma A, van Duijnhoven FJ, Jung AY, Kleibeuker JH, Nagengast FM, Vasen HF, Kampman E.

PLoS One. 2013 Jun 18;8(6):e66819. doi: 10.1371/journal.pone.0066819. Print 2013.

23.

Carrier density modulation by structural distortions at modified LaAlO3/SrTiO3 interfaces.

Schoofs F, Carpenter MA, Vickers ME, Egilmez M, Fix T, Kleibeuker JE, MacManus-Driscoll JL, Blamire MG.

J Phys Condens Matter. 2013 May 1;25(17):175005. doi: 10.1088/0953-8984/25/17/175005. Epub 2013 Apr 8.

PMID:
23567541
24.

Features of adenoma and colonoscopy associated with recurrent colorectal neoplasia based on a large community-based study.

van Heijningen EM, Lansdorp-Vogelaar I, Kuipers EJ, Dekker E, Lesterhuis W, Ter Borg F, Vecht J, De Jonge V, Spoelstra P, Engels L, Bolwerk CJ, Timmer R, Kleibeuker JH, Koornstra JJ, van Ballegooijen M, Steyerberg EW.

Gastroenterology. 2013 Jun;144(7):1410-8. doi: 10.1053/j.gastro.2013.03.002. Epub 2013 Mar 7.

PMID:
23499951
25.

Role of new endoscopic techniques in Lynch syndrome.

Haanstra JF, Kleibeuker JH, Koornstra JJ.

Fam Cancer. 2013 Jun;12(2):267-72. doi: 10.1007/s10689-013-9610-6. Review.

PMID:
23420551
26.

Dietary patterns and colorectal adenomas in Lynch syndrome: the GEOLynch cohort study.

Botma A, Vasen HF, van Duijnhoven FJ, Kleibeuker JH, Nagengast FM, Kampman E.

Cancer. 2013 Feb 1;119(3):512-21. doi: 10.1002/cncr.27726. Epub 2012 Dec 17. Erratum in: Cancer. 2013 Jun 15;119(12):2358.

27.

Letter: detection of infliximab levels and anti-infliximab antibodies--comparison of three different assays; authors' reply.

Buurman DJ, Vande Casteele N, Sturkenboom MG, Kleibeuker JH, Vermeire S, van der Kleij D, Rispens T, Gils A, Dijkstra G.

Aliment Pharmacol Ther. 2013 Jan;37(2):282. doi: 10.1111/apt.12128. No abstract available.

28.

Targeting FLIP and Mcl-1 using a combination of aspirin and sorafenib sensitizes colon cancer cells to TRAIL.

Pennarun B, Kleibeuker JH, Boersma-van Ek W, Kruyt FA, Hollema H, de Vries EG, de Jong S.

J Pathol. 2013 Feb;229(3):410-21. doi: 10.1002/path.4138.

PMID:
23132258
29.

Detection of infliximab levels and anti-infliximab antibodies: a comparison of three different assays.

Vande Casteele N, Buurman DJ, Sturkenboom MG, Kleibeuker JH, Vermeire S, Rispens T, van der Kleij D, Gils A, Dijkstra G.

Aliment Pharmacol Ther. 2012 Oct;36(8):765-71. doi: 10.1111/apt.12030. Epub 2012 Aug 28.

30.

Quality of life after surgery for colon cancer in patients with Lynch syndrome: partial versus subtotal colectomy.

Haanstra JF, de Vos Tot Nederveen Cappel WH, Gopie JP, Vecht J, Vanhoutvin SA, Cats A, van der Zaag-Loonen HJ, Langers AM, Bergmann JH, van de Meeberg PC, Dekker E, Kleibeuker JH, Vasen HF, Nagengast FM, van Duijvendijk P.

Dis Colon Rectum. 2012 Jun;55(6):653-9. doi: 10.1097/DCR.0b013e31824f5392.

PMID:
22595844
31.

Diagnostic yield of small bowel capsule endoscopy depends on the small bowel transit time.

Westerhof J, Koornstra JJ, Hoedemaker RA, Sluiter WJ, Kleibeuker JH, Weersma RK.

World J Gastroenterol. 2012 Apr 7;18(13):1502-7. doi: 10.3748/wjg.v18.i13.1502.

32.

Smoking increases the risk for colorectal adenomas in patients with Lynch syndrome.

Winkels RM, Botma A, Van Duijnhoven FJ, Nagengast FM, Kleibeuker JH, Vasen HF, Kampman E.

Gastroenterology. 2012 Feb;142(2):241-7. doi: 10.1053/j.gastro.2011.10.033. Epub 2011 Nov 4.

PMID:
22062356
33.

Metallic and insulating interfaces of amorphous SrTiO₃-based oxide heterostructures.

Chen Y, Pryds N, Kleibeuker JE, Koster G, Sun J, Stamate E, Shen B, Rijnders G, Linderoth S.

Nano Lett. 2011 Sep 14;11(9):3774-8. doi: 10.1021/nl201821j. Epub 2011 Aug 10.

PMID:
21823637
34.

Inhibition of IGF-1R-dependent PI3K activation sensitizes colon cancer cells specifically to DR5-mediated apoptosis but not to rhTRAIL.

Pennarun B, Kleibeuker JH, Oenema T, Stegehuis JH, de Vries EG, de Jong S.

Cell Oncol (Dordr). 2011 Jun;34(3):245-59. doi: 10.1007/s13402-011-0033-9. Epub 2011 Apr 30.

PMID:
21538027
35.

Paediatric intestinal cancer and polyposis due to bi-allelic PMS2 mutations: case series, review and follow-up guidelines.

Herkert JC, Niessen RC, Olderode-Berends MJ, Veenstra-Knol HE, Vos YJ, van der Klift HM, Scheenstra R, Tops CM, Karrenbeld A, Peters FT, Hofstra RM, Kleibeuker JH, Sijmons RH.

Eur J Cancer. 2011 May;47(7):965-82. doi: 10.1016/j.ejca.2011.01.013. Epub 2011 Mar 4. Review.

PMID:
21376568
36.

Total abdominal 18F-FDG uptake reflects intestinal adenoma burden in Apc mutant mice.

Heijink DM, Kleibeuker JH, Nagengast WB, Oosterhuis D, Brouwers AH, Koornstra JJ, de Jong S, de Vries EG.

J Nucl Med. 2011 Mar;52(3):431-6. doi: 10.2967/jnumed.110.083956. Epub 2011 Feb 14.

37.

A bioinformatical and functional approach to identify novel strategies for chemoprevention of colorectal cancer.

Heijink DM, Fehrmann RS, de Vries EG, Koornstra JJ, Oosterhuis D, van der Zee AG, Kleibeuker JH, de Jong S.

Oncogene. 2011 Apr 28;30(17):2026-36. doi: 10.1038/onc.2010.578. Epub 2011 Jan 10.

PMID:
21217777
38.

Effects of active and passive smoking on Crohn's disease and ulcerative colitis in a cohort from a regional hospital.

van der Heide F, Wassenaar M, van der Linde K, Spoelstra P, Kleibeuker JH, Dijkstra G.

Eur J Gastroenterol Hepatol. 2011 Mar;23(3):255-61. doi: 10.1097/MEG.0b013e3283435233.

PMID:
21191306
39.

TNF-related apoptosis-inducing ligand cooperates with NSAIDs via activated Wnt signalling in (pre)malignant colon cells.

Heijink DM, Jalving M, Oosterhuis D, Sloots IA, Koster R, Hollema H, Kleibeuker JH, Koornstra JJ, de Vries EG, de Jong S.

J Pathol. 2011 Feb;223(3):378-89. doi: 10.1002/path.2797. Epub 2010 Oct 29.

PMID:
21171083
40.

Perspectives for tailored chemoprevention and treatment of colorectal cancer in Lynch syndrome.

Heijink DM, de Vries EG, Koornstra JJ, Hospers GA, Hofstra RM, van Vugt MA, de Jong S, Kleibeuker JH.

Crit Rev Oncol Hematol. 2011 Nov;80(2):264-77. doi: 10.1016/j.critrevonc.2010.11.009. Epub 2010 Dec 14. Review.

PMID:
21159521
41.

Active and passive smoking behaviour and cessation plans of patients with Crohn's disease and ulcerative colitis.

van der Heide F, Dijkstra A, Albersnagel FA, Kleibeuker JH, Dijkstra G.

J Crohns Colitis. 2010 Jun;4(2):125-31. doi: 10.1016/j.crohns.2009.09.005. Epub 2009 Dec 1.

PMID:
21122495
42.

Evaluation of management of desmoid tumours associated with familial adenomatous polyposis in Dutch patients.

Nieuwenhuis MH, Mathus-Vliegen EM, Baeten CG, Nagengast FM, van der Bijl J, van Dalsen AD, Kleibeuker JH, Dekker E, Langers AM, Vecht J, Peters FT, van Dam R, van Gemert WG, Stuifbergen WN, Schouten WR, Gelderblom H, Vasen HF.

Br J Cancer. 2011 Jan 4;104(1):37-42. doi: 10.1038/sj.bjc.6605997. Epub 2010 Nov 9.

43.

Deficiencies in fat-soluble vitamins in long-term users of somatostatin analogue.

Fiebrich HB, Van Den Berg G, Kema IP, Links TP, Kleibeuker JH, Van Beek AP, Walenkamp AM, Sluiter WJ, De Vries EG.

Aliment Pharmacol Ther. 2010 Dec;32(11-12):1398-404. doi: 10.1111/j.1365-2036.2010.04479.x. Epub 2010 Oct 7.

44.

Inhibition of IGF-1R-dependent PI3K activation sensitizes colon cancer cells specifically to DR5-mediated apoptosis but not to rhTRAIL.

Pennarun B, Kleibeuker JH, Oenema T, Stegehuis JH, de Vries EG, de Jong S.

Anal Cell Pathol (Amst). 2010;33(5):229-44. doi: 10.3233/ACP-CLO-2010-0549.

45.

High detection rate of adenomas in familial colorectal cancer.

van der Meulen-de Jong AE, Morreau H, Becx MC, Crobach LF, van Haastert M, ten Hove WR, Kleibeuker JH, Meijssen MA, Nagengast FM, Rijk MC, Salemans JM, Stronkhorst A, Tuynman HA, Vecht J, Verhulst ML, de Vos tot Nederveen Cappel WH, Walinga H, Weinhardt OK, Westerveld BD, Witte AM, Wolters HJ, Vasen HF.

Gut. 2011 Jan;60(1):73-6. doi: 10.1136/gut.2010.217091. Epub 2010 Sep 9.

PMID:
20833659
46.

Body mass index increases risk of colorectal adenomas in men with Lynch syndrome: the GEOLynch cohort study.

Botma A, Nagengast FM, Braem MG, Hendriks JC, Kleibeuker JH, Vasen HF, Kampman E.

J Clin Oncol. 2010 Oct 1;28(28):4346-53. doi: 10.1200/JCO.2010.28.0453. Epub 2010 Aug 23.

PMID:
20733131
47.

Low-volume PEG plus ascorbic acid versus high-volume PEG as bowel preparation for colonoscopy.

Corporaal S, Kleibeuker JH, Koornstra JJ.

Scand J Gastroenterol. 2010 Nov;45(11):1380-6. doi: 10.3109/00365521003734158. Epub 2010 Jul 5.

PMID:
20602568
48.

Parallel electron-hole bilayer conductivity from electronic interface reconstruction.

Pentcheva R, Huijben M, Otte K, Pickett WE, Kleibeuker JE, Huijben J, Boschker H, Kockmann D, Siemons W, Koster G, Zandvliet HJ, Rijnders G, Blank DH, Hilgenkamp H, Brinkman A.

Phys Rev Lett. 2010 Apr 23;104(16):166804. Epub 2010 Apr 23.

PMID:
20482074
49.

Cytomegalovirus infection increases the risk for inflammatory bowel disease.

Verdonk RC, Haagsma EB, Kleibeuker JH, Dijkstra G, Sudan DL.

Am J Pathol. 2010 Jun;176(6):3098. doi: 10.2353/ajpath.2010.100101. Epub 2010 Apr 15.

50.

One to 2-year surveillance intervals reduce risk of colorectal cancer in families with Lynch syndrome.

Vasen HF, Abdirahman M, Brohet R, Langers AM, Kleibeuker JH, van Kouwen M, Koornstra JJ, Boot H, Cats A, Dekker E, Sanduleanu S, Poley JW, Hardwick JC, de Vos Tot Nederveen Cappel WH, van der Meulen-de Jong AE, Tan TG, Jacobs MA, Mohamed FL, de Boer SY, van de Meeberg PC, Verhulst ML, Salemans JM, van Bentem N, Westerveld BD, Vecht J, Nagengast FM.

Gastroenterology. 2010 Jun;138(7):2300-6. doi: 10.1053/j.gastro.2010.02.053. Epub 2010 Mar 2.

PMID:
20206180

Supplemental Content

Loading ...
Support Center